Comparison of microfluid sperm sorting chip and density gradient methods for use in intrauterine insemination cycles.
Funda Gode, Taylan Bodur, Fatma Gunturkun...
https://pubmed.ncbi.nlm.nih.gov/31543253/Actively Recruiting
Led by Universitair Ziekenhuis Brussel · Updated on 2024-01-30
240
Participants Needed
1
Research Sites
52 weeks
Total Duration
This research aims to compare two sperm preparation methods for couples undergoing Intra Uterine Insemination IUI as a treatment for infertility, including mild male factor infertility, anovulation, endometriosis, unexplained infertility, lesbian couples, or single women using donor sperm. The study evaluates whether using the ZyMt Multi 850L sperm separation device improves live birth rates compared to the standard Density Gradient Centrifugation DGC method. This pilot randomized controlled trial is conducted at a single center and plans to enroll couples referred for IUI with fresh autologous semen. Participants will be randomly assigned to either the standard DGC sperm preparation or the ZyMt Multi device group. The DGC method separates sperm based on density using centrifugation steps with silica particle gradients, while the ZyMt Multi device uses a chemical-free, microfluidic sorting process without centrifugation to select motile, morphologically normal sperm. The selected sperm are then used in up to three consecutive IUI attempts within six months, maintaining the assigned sperm preparation method throughout. During the study, couples will undergo IUI procedures using the sperm selected by their assigned method, followed by monitoring for pregnancy, clinical pregnancy, and neonatal outcomes. The primary outcome measured is the cumulative live birth rate after three IUIs within nine months. Secondary outcomes include pregnancy and miscarriage rates within specified timeframes. The study includes detailed semen processing, ultrasound monitoring of follicles and tubes, and follow-up on pregnancy outcomes.
CONDITIONS
Live Birth Rate After Sperm Selection Using ZyMōt Multi (850µL) Device for Intra Uterine Insemination
E
Elsie Nulens
I
Ileana Mateizel, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Universitair Ziekenhuis Brussel
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 6 months
Participants undergo up to 3 consecutive intrauterine insemination (IUI) procedures using either the ZyMōt Multi (850µL) device or Density Gradient Centrifugation (DGC) sperm selection method.
Up to 3 IUI visits
Duration - Up to 9 months following the first IUI
Participants are monitored for pregnancy outcomes, including pregnancy confirmation, miscarriage, and live birth after the IUI procedures.
Approximately 3 visits for pregnancy assessment and monitoring
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Funda Gode, Taylan Bodur, Fatma Gunturkun...
https://pubmed.ncbi.nlm.nih.gov/31543253/Universitair Ziekenhuis Brussel
Lead Sponsor